收藏切换
The mechanism of ShengMaiSan reducing calcium leak and protecting myocardial contractile function in diabetic rats based on network pharmacology
收藏切换
PDF
Cong HUANG1, Ming-jie SUN1, Hai-feng CUI1, Li-hua SUN1, QIAN WU1, Qu ZHAI2, Xiao-lu SHI1, *
Acta Pharmaceutica Sinica | 2022, 57(10) : 3115 - 3123
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(10): 3115-3123
Special Reports Ⅱ: Traditional Chinese Medicine in the Prevention and Treatment of Cardio-cerebrovascular Related Diseases
The mechanism of ShengMaiSan reducing calcium leak and protecting myocardial contractile function in diabetic rats based on network pharmacology
Full
Cong HUANG1, Ming-jie SUN1, Hai-feng CUI1, Li-hua SUN1, QIAN WU1, Qu ZHAI2, Xiao-lu SHI1, *
Affiliations
  • 1. Key Laboratory of TCM Basic Research on Prevention and Treatment of Major Disease, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • 2. National Medical Products Administration Institute of Executive Development, Beijing 100073, China
Published: 2022-10-12 doi: 10.16438/j.0513-4870.2022-0482
Outline
收藏切换

In this study, network pharmacology research and animal experiments were used to predict and validate the potential targets of ShengMaiSan (SMS) in the treatment of diabetic cardiomyopathy. The active components of SMS were obtained through TCMSP and BATMAN databases. The potential targets of the active components and diabetic cardiomyopathy were predicted by Swiss Target Prediction and GeneCards databases, respectively. The protein-protein interaction (PPI) network was constructed by String database. Cytoscape software was adopted to perform topological analysis to select the core action target. Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses were performed using Metascape platform. To validate the potential targets, a type I diabetic rat model which induced by intraperitoneal injection of streptozotocin (STZ) was prepared. Rats were divided into sham group, model group, SMS group and trimetazidine (TMZ) group. Left ventricular hemodynamics was detected after 4 weeks administrated of SMS or TMZ. Myocardial contraction and calcium transients were detected synchronously in cardiomyocytes, as well as sarcoplasmic reticulum calcium content, calcium leak level and ryanodine receptor 2 (RyR2) expression were detected. Based on network pharmacology, 1 288 targets of SMS, 1 066 targets of diabetic cardiomyopathy, and 180 overlapped targets were obtained. The 39 core targets were screened, and 159 pathways including calcium signaling pathway were screened by KEGG pathway analysis. According to the previous studies and focusing on the contractility of diabetic cardiomyopathy, this study was involved calcium signaling regulation pathway in the SMS protection mechanism. The results showed that, compared with sham group, the systolic function of left ventricular and myocardial cells were decreased, and the calcium transport was in disorder in model group; compared with model group, both SMS group and TMZ group increased the maximum systolic pressure of left ventricle and the maximum systolic rate of left ventricular contraction. In addition, SMS group and TMZ group increased the contraction amplitude of cardiomyocytes, decreased the diastolic calcium concentration, the sarcoplasmic reticulum calcium leak and decreased the phosphorylation level of RyR2. There was no significant difference between SMS and TMZ groups. In summary, SMS could reduce the calcium leak of the sarcoplasmic reticulum and enhance the myofilament sensitivity of calcium to increasing contractile function of diabetic rats. The animal welfare and experiment procedures of this study were in accordance with the regulations of the Experimental Animal Ethics Committee of Experimental Research Center, China Academy of Chinese Medical Sciences.

ShengMaiSan  /  diabetic cardiomyopathy  /  calcium transport  /  calcium leak  /  network pharmacology
Cong HUANG, Ming-jie SUN, Hai-feng CUI, Li-hua SUN, QIAN WU, Qu ZHAI, Xiao-lu SHI. The mechanism of ShengMaiSan reducing calcium leak and protecting myocardial contractile function in diabetic rats based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2022 , 57 (10) : 3115 -3123 . DOI: 10.16438/j.0513-4870.2022-0482
Year 2022 volume 57 Issue 10
PDF
166
72
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0482
  • Receive Date:2022-04-24
  • Online Date:2025-12-24
  • Published:2022-10-12
Article Data
Affiliations
History
  • Received:2022-04-24
  • Revised:2022-05-25
Funding
Affiliations
    1. Key Laboratory of TCM Basic Research on Prevention and Treatment of Major Disease, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
    2. National Medical Products Administration Institute of Executive Development, Beijing 100073, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0482
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT